Ustekinumab May Be Effective for Lupus

New research underscores the possibility that interleukin (IL) 12, IL-23 or both play roles in the immunopathology of SLE. In the study, when added to standard-of-care treatment for active SLE, ustekinumab demonstrated better efficacy than placebo and had a safety profile consistent with that of ustekinumab therapy in other diseases...

Source: The Rheumatologist - November 12, 2018 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions SLE (Lupus) systemic lupus erythematosus (SLE) ustekinumab Source Type: research